|  | Early Mortality vs. Lived | P-value | Early recurrence vs. Non-recurrence | P-value |
---|---|---|---|---|---|
RAM scorea (mean ± SE) |  | 5.52 ± 0.17 vs. 3.85 ± 0.05 | <0.001 | 4.34 ± 0.06 vs.3.35 ± 0.06 | <0.001 |
ALBI scoreb (mean ± SE) |  | −2.47 ± 0.04 vs. -2.81 ± 0.01 | <0.001 | −2.71 ± 0.01 vs. -2.86 ± 0.01 | <0.001 |
MELD scorec (mean ± SE) |  | 9.32 ± 0.33 vs. 8.27 ± 0.07 | 0.002 | 8.54 ± 0.09 vs. 8.23 ± 0.10 | 0.113 |
 | Number (% of total) | Early mortality (6-month) (%) | P-value | Early recurrence (2-year) (%) | P-value |
RAM scorea (n = 1935) |  |  | <0.001 |  | <0.001 |
 RAM class I | 1702 (88) | 101 (5.9) |  | 887 (52.6%) |  |
 RAM class II/III | 233 (12) | 48 (20.6) |  | 148 (68.2%) |  |
ALBI scoreb (n = 1892) |  |  | <0.001 |  | <0.001 |
 ALBI grade 1 | 1341 (70.9) | 67 (5.0) |  | 666 (49.7%) |  |
 ALBI grade 2 | 541 (28.6) | 75 (13.9) |  | 339 (62.7%) |  |
 ALBI grade 3 | 10 (0.5) | 2 (20.0) |  | 7 (70.0%) |  |
MELD scorec (n = 1898) |  |  | 0.002 |  | 0.106 |
 MELD grade 1 | 1513 (79.7) | 97 (6.4) |  | 799 (53.5%) |  |
 MELD grade 2 | 319 (16.8) | 37 (11.6) |  | 183 (58.7%) |  |
 MELD grade 3 | 66 (3.5) | 8 (12.1) |  | 28 (45.9%) |  |